Why Bipolar Depression Gets Misdiagnosed

People with bipolar disorder spend significantly more time in depressive episodes than in manic or hypomanic ones. In bipolar I disorder, the ratio of depressive to manic days is approximately 3:1; in bipolar II, depressive episodes are even more predominant relative to hypomanic ones. This means that most people with bipolar disorder first seek treatment during a depressive episode — and the depressive episode looks, symptomatically, identical to major depression.

The DSM-5 criteria for a major depressive episode are the same whether the episode occurs in the context of bipolar disorder or unipolar MDD. Low mood, anhedonia, fatigue, sleep and appetite changes, cognitive impairment, feelings of worthlessness, and suicidal ideation are present in both. A cross-sectional assessment of a bipolar patient in depression cannot be distinguished from an assessment of a unipolar depressed patient without additional history.

The average delay from first symptom onset to correct bipolar disorder diagnosis is approximately 6–10 years. During this interval, most patients receive an MDD diagnosis and antidepressant treatment — which can worsen the course of bipolar disorder significantly. The misdiagnosis is not a failure of clinical skill in the simple sense; it reflects the inherent diagnostic challenge of a condition that is frequently first encountered in its depressive phase.

The diagnostic key is the history for hypomanic or manic episodes. These episodes are often not spontaneously reported because patients may not recognize them as pathological — hypomanic periods often feel like natural high-energy states, periods of exceptional productivity, or simply feeling good. Without direct questioning, many patients never connect these periods to the depression they are seeking treatment for. A thorough bipolar screening includes specific questions about prior periods of elevated mood, decreased need for sleep without fatigue, racing thoughts, increased goal-directed activity, and impulsive behaviors.

How the Treatment Differs

The treatment distinction between bipolar depression and major depression is one of the most clinically consequential differences in psychiatry. Getting it wrong can significantly worsen the condition being treated.

Major depressive disorder treatment: SSRIs and SNRIs are the evidence-based first-line treatment. The standard approach is to begin an SSRI at low dose, titrate to therapeutic dose over the first weeks, and assess response at 4–8 weeks. For partial response, augmentation or switching is considered. Antidepressants are safe and effective for MDD and do not carry the destabilization risk that bipolar disorder does.

Bipolar depression treatment: Antidepressants without mood stabilizer coverage are specifically not recommended as monotherapy for bipolar depression because of the risk of precipitating mania, hypomania, mixed states, or rapid cycling. The evidence-based approach to bipolar depression uses mood stabilizers (lithium, lamotrigine) or atypical antipsychotics with evidence for bipolar depression (quetiapine, lurasidone, cariprazine, olanzapine-fluoxetine combination) as the primary agents. Antidepressants may be used as adjuncts with mood stabilizer coverage in select cases, but the clinical risk must be weighed carefully.

Lamotrigine is particularly important for bipolar depression — it has the best evidence for preventing bipolar depressive episodes in maintenance and is well-tolerated, but requires a slow titration schedule to avoid the rash risk (including Stevens-Johnson syndrome). It takes weeks to reach therapeutic doses, which is one reason early accurate diagnosis matters.

When antidepressants are given to unrecognized bipolar patients, the most common outcomes are: switching to hypomania or mania; development of mixed states (simultaneous depressive and manic symptoms, often with elevated suicide risk); and acceleration of cycling frequency. These outcomes worsen the course of bipolar disorder and can take months to correct after the antidepressant is identified as the problem and discontinued.

How to Tell Them Apart

The most reliable way to distinguish bipolar depression from unipolar depression is a careful, directed history for hypomanic and manic episodes. This requires asking specifically about prior periods of elevated or expansive mood, decreased need for sleep without feeling tired, increased energy and goal-directed activity, racing thoughts, rapid speech, grandiosity, and impulsive behaviors — asking not just whether these occurred but when, for how long, and what their impact was.

Several clinical features within the depressive episode itself increase the probability of bipolar rather than unipolar depression: atypical features (mood reactivity, hypersomnia, leaden fatigue, rejection sensitivity); psychotic features; depressive mixed states (depression with irritability, agitation, and racing thoughts simultaneously); onset before age 25; first-degree relative with bipolar disorder; and prior antidepressant-induced hypomanic or manic switch. None of these features is diagnostic alone, but together they raise the pre-test probability of bipolar disorder enough to require careful bipolar screening before starting antidepressant monotherapy.

Standardized screening tools including the Mood Disorder Questionnaire (MDQ) and the Hypomania Checklist-32 (HCL-32) can assist in identifying patients who warrant more detailed bipolar evaluation. A positive screen is not a diagnosis but a signal to explore the history in more depth.

ETX Psychiatry takes careful bipolar screening seriously in all initial psychiatric evaluations. Call (430) 288-5800 or schedule online. We accept Medicare, Aetna, BCBS, Cigna, Optum, UHC, UMR, and Ambetter. 100 Independence Pl, Suite 405, Tyler, TX 75703. Telehealth available.

Getting the Right Diagnosis in East Texas

For patients in East Texas who have been treated for depression without adequate response — particularly those who have experienced activation, agitation, or worsening mood on antidepressants, or who have had periods of elevated mood and energy they have never discussed with a provider — a comprehensive bipolar screening as part of a psychiatric evaluation is a valuable step. The evaluation does not require prior records or referral, and the history can be gathered in a single comprehensive appointment.

The clinical consequences of treating bipolar disorder as MDD are significant and preventable. Early accurate diagnosis changes the treatment approach in ways that reduce episode frequency, stabilize mood, and protect long-term functioning. The average 6–10 year delay to correct diagnosis represents years of potential preventable suffering for patients whose bipolar disorder was unrecognized. ETX Psychiatry takes the diagnostic distinction between bipolar and unipolar depression seriously as a foundational clinical priority.

We serve Tyler, Longview, Lufkin, Nacogdoches, and patients across East Texas via telehealth. No referral required. Call (430) 288-5800 to schedule.